174 related articles for article (PubMed ID: 38285100)
1. Predictive tissue markers in testicular germ cell tumors: Immunohistochemical expression of MLH1 and REV-7 proteins.
Spinos T; Zografos E; Koutsoukos K; Zagouri F; Kosmas C; Driva TS; Goutas D; Gakiopoulou C; Agrogiannis G; Theochari E; Tzavara C; Lazaris AC
Int Urol Nephrol; 2024 Jun; 56(6):1887-1898. PubMed ID: 38285100
[TBL] [Abstract][Full Text] [Related]
2. Expression of CD44 is associated with aggressiveness in seminomas.
Labropoulou VT; Manou D; Ravazoula P; Alzahrani FM; Kalofonos HP; Theocharis AD
Mol Biol Rep; 2024 May; 51(1):693. PubMed ID: 38796656
[TBL] [Abstract][Full Text] [Related]
3. APAF-1 is related to an undifferentiated state in the testicular germ cell tumor pathway.
Behjati R; Kawai K; Inadome Y; Kano J; Akaza H; Noguchi M
Cancer Sci; 2011 Jan; 102(1):267-74. PubMed ID: 20977544
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of programmed-death-1 receptor (PD-1) and its ligand 1 (PD-L1) in testicular germ cell tumors.
Cierna Z; Mego M; Miskovska V; Machalekova K; Chovanec M; Svetlovska D; Hainova K; Rejlekova K; Macak D; Spanik S; Ondrus D; Kajo K; Mardiak J; Babal P
Ann Oncol; 2016 Feb; 27(2):300-5. PubMed ID: 26598537
[TBL] [Abstract][Full Text] [Related]
5. The Immunohistochemical Expression of REV-7 in Various Human Cancer Pathology Specimens: A Systematic Review.
Spinos T; Goutas D; Driva TS; Zografos E; Gakiopoulou C; Agrogiannis G; Zolota V; Tzelepi V; Manolis I; Koniaris E; Ioannou M; Lazaris AC
Cureus; 2024 Jan; 16(1):e52542. PubMed ID: 38371007
[TBL] [Abstract][Full Text] [Related]
6. Molecular Mechanisms of Cisplatin Chemoresistance and Its Circumventing in Testicular Germ Cell Tumors.
Schmidtova S; Kalavska K; Kucerova L
Curr Oncol Rep; 2018 Sep; 20(11):88. PubMed ID: 30259297
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of intratumoral carbonic anhydrase IX expression in testicular germ cell tumors.
Kalavska K; Cierna Z; Chovanec M; Takacova M; Svetlovska D; Miskovska V; Obertova J; Palacka P; Rajec J; Sycova-Mila Z; Machalekova K; Kajo K; Spanik S; Mardiak J; Babal P; Pastorekova S; Mego M
Oncol Lett; 2017 Apr; 13(4):2177-2185. PubMed ID: 28454378
[TBL] [Abstract][Full Text] [Related]
8. Prognostic role of programmed-death ligand 1 (PD-L1) expressing tumor infiltrating lymphocytes in testicular germ cell tumors.
Chovanec M; Cierna Z; Miskovska V; Machalekova K; Svetlovska D; Kalavska K; Rejlekova K; Spanik S; Kajo K; Babal P; Mardiak J; Mego M
Oncotarget; 2017 Mar; 8(13):21794-21805. PubMed ID: 28423520
[TBL] [Abstract][Full Text] [Related]
9. Assessment of piRNA biogenesis and function in testicular germ cell tumors and their precursor germ cell neoplasia in situ.
Gainetdinov IV; Skvortsova YV; Kondratieva SA; Klimov A; Tryakin AA; Azhikina TL
BMC Cancer; 2018 Jan; 18(1):20. PubMed ID: 29301509
[TBL] [Abstract][Full Text] [Related]
10. Testicular germ cell tumors: a clinicopathological and immunohistochemical analysis of 145 cases.
Zhang T; Ji L; Liu B; Guan W; Liu Q; Gao Y
Int J Clin Exp Pathol; 2018; 11(9):4622-4629. PubMed ID: 31949861
[TBL] [Abstract][Full Text] [Related]
11. Higher expression of SALL4-A isoform is correlated with worse outcomes and progression of the disease in subtype of testicular germ cell tumours.
Lakpour N; Ghods R; Abolhasani M; Saeednejad Zanjani L; Saliminejad K; Kalantari E; Saki S; Ranjbar MM; Balay-Goli L; Sadeghi MR; Madjd Z
Biomarkers; 2024 Jun; ():1-16. PubMed ID: 38808385
[TBL] [Abstract][Full Text] [Related]
12. Expression of syndecan-4 and correlation with metastatic potential in testicular germ cell tumours.
Labropoulou VT; Skandalis SS; Ravazoula P; Perimenis P; Karamanos NK; Kalofonos HP; Theocharis AD
Biomed Res Int; 2013; 2013():214864. PubMed ID: 23844358
[TBL] [Abstract][Full Text] [Related]
13. The Warburg Effect Is Associated With Tumor Aggressiveness in Testicular Germ Cell Tumors.
Bonatelli M; Silva ECA; Cárcano FM; Zaia MG; Lopes LF; Scapulatempo-Neto C; Pinheiro C
Front Endocrinol (Lausanne); 2019; 10():417. PubMed ID: 31316469
[TBL] [Abstract][Full Text] [Related]
14. Spermatogenesis in tumor-bearing testes in germ cell testicular cancer patients.
Suzuki K; Shin T; Shimomura Y; Iwahata T; Okada H
Hum Reprod; 2015 Dec; 30(12):2853-8. PubMed ID: 26428212
[TBL] [Abstract][Full Text] [Related]
15. [Polymorphisms of KITLG, SPRY4, and BAK1 genes in patients with testicular germ cell tumors and individuals with infertility associated with AZFc deletion of the Y chromosome].
Nemtsova MV; Ivkin EV; Simonova OA; Rudenko VV; Chernykh VB; Mikhaylenko DS; Loran OB
Mol Biol (Mosk); 2016; 50(6):960-967. PubMed ID: 28064312
[TBL] [Abstract][Full Text] [Related]
16. Novel sequential therapy with metformin enhances the effects of cisplatin in testicular germ cell tumours via YAP1 signalling.
He K; Li Z; Ye K; Zhou Y; Yan M; Qi H; Hu H; Dai Y; Tang Y
Cancer Cell Int; 2022 Mar; 22(1):113. PubMed ID: 35264157
[TBL] [Abstract][Full Text] [Related]
17. Integrated Microarray-Based Data Analysis of miRNA Expression Profiles: Identification of Novel Biomarkers of Cisplatin-Resistance in Testicular Germ Cell Tumours.
Roška J; Lobo J; Ivovič D; Wachsmannová L; Mueller T; Henrique R; Jerónimo C; Chovanec M; Jurkovičová D
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768818
[TBL] [Abstract][Full Text] [Related]
18. Disulfiram Overcomes Cisplatin Resistance in Human Embryonal Carcinoma Cells.
Schmidtova S; Kalavska K; Gercakova K; Cierna Z; Miklikova S; Smolkova B; Buocikova V; Miskovska V; Durinikova E; Burikova M; Chovanec M; Matuskova M; Mego M; Kucerova L
Cancers (Basel); 2019 Aug; 11(9):. PubMed ID: 31443351
[TBL] [Abstract][Full Text] [Related]
19. Molecular and cell biology of testicular germ cell tumors.
Chieffi P; Franco R; Portella G
Int Rev Cell Mol Biol; 2009; 278():277-308. PubMed ID: 19815181
[TBL] [Abstract][Full Text] [Related]
20. Association of Inherited Pathogenic Variants in Checkpoint Kinase 2 (CHEK2) With Susceptibility to Testicular Germ Cell Tumors.
AlDubayan SH; Pyle LC; Gamulin M; Kulis T; Moore ND; Taylor-Weiner A; Hamid AA; Reardon B; Wubbenhorst B; Godse R; Vaughn DJ; Jacobs LA; Meien S; Grgic M; Kastelan Z; Markt SC; Damrauer SM; Rader DJ; Kember RL; Loud JT; Kanetsky PA; Greene MH; Sweeney CJ; Kubisch C; Nathanson KL; Van Allen EM; Stewart DR; Lessel D;
JAMA Oncol; 2019 Apr; 5(4):514-522. PubMed ID: 30676620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
